Synthesis and Antimicrobial Evaluation of Novel Oxopyrimido[1,2–a]pyrimidine Derivatives
BioMed and BioSci Advances · 2025
DOI: 10.69626/bba.2025.0158 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed and BioSci Advances, 2025. Verfasst von Jadhav Madhav S und 3 weiteren Autor:innen.
Abstract (Originalsprache)
This study details the efficient synthesis and antimicrobial evaluation of a novel series of oxopyrimido[1,2-a]pyrimidine derivatives. The synthetic pathway commenced with the preparation of a key chalcone intermediate, 3-(4-chlorophenyl)-1-phenylprop-2-en-1-one, via a Claisen-Schmidt condensation of 4-chlorobenzaldehyde and acetophenone. This chalcone was subsequently cyclized with guanidine nitrate under basic conditions to yield the pivotal dihydropyrimidin-2-amine precursor. The core pyrimidopyrimidine scaffold was constructed through a Michael addition reaction, where the dihydropyrimidin-2-amine was reacted with ethyl 2-cyano-3,3-bis(methylthio)acrylate. This crucial step afforded the central intermediate, 2-(4-chlorophenyl)-8-(methylthio)-6-oxo-4-phenyl-1,6,9,9a-tetrahydro-2H-pyrimido[1,2-a]pyrimidine-7-carbonitrile, which features a reactive methylthio group. This group served as a versatile handle for further functionalization, allowing for the synthesis of a diverse library of ten new analogues through nucleophilic substitution with various aromatic amines, phenols, and active methylene compounds. The structures of all synthesized compounds were unequivocally confirmed using modern spectroscopic techniques, including IR, ¹H NMR, ¹³C NMR, and mass spectrometry. The entire compound library was screened for in vitro antibacterial and antifungal activities. The results were promising, with several derivatives exhibiting significant growth inhibition against strains of Escherichia coli, Bacillus subtilis, Aspergillus niger, and Aspergillus flavus, showcasing their potential as leads for new antimicrobial agents.
Zitieren
APA
S, J. M., B, S. S., G, J. A., & V, S. N. (2025). Synthesis and Antimicrobial Evaluation of Novel Oxopyrimido[1,2–a]pyrimidine Derivatives. BioMed and BioSci Advances. https://doi.org/10.69626/bba.2025.0158
Vancouver
S JM, B SS, G JA, V SN. Synthesis and Antimicrobial Evaluation of Novel Oxopyrimido[1,2–a]pyrimidine Derivatives. BioMed and BioSci Advances. 2025. doi:10.69626/bba.2025.0158
BibTeX
@article{S2025,
author = {S, Jadhav Madhav and B, Sirsat Shivraj and G, Jadhav Anilkumar and V, Shitole Nana},
title = {Synthesis and Antimicrobial Evaluation of Novel Oxopyrimido[1,2–a]pyrimidine Derivatives},
journal = {BioMed and BioSci Advances},
year = {2025},
doi = {10.69626/bba.2025.0158}
}
EUVIMED